Literature DB >> 32466507

Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease.

Beatriz Fernandez-Fernandez1,2, Ignacio Mahillo1, Jinny Sanchez-Rodriguez1,2, Sol Carriazo1,2, Ana B Sanz1,2, Maria Dolores Sanchez-Niño1,2, Alberto Ortiz1,2.   

Abstract

BACKGROUND: Women are reported to have a lower incidence of renal replacement therapy, despite a higher prevalence of chronic kidney disease (CKD). AIM: To analyze diabetic kidney disease (DKD) progression in men and women.
METHODS: Prospective cohort: n = 261, 35% women, new consecutive nephrology DKD referrals.
RESULTS: Women smoked less and better complied with the dietary phosphate and sodium restrictions. Despite a less frequent nephrology referral, women had lower baseline albuminuria. Over a 30 ± 10-month follow-up, albuminuria decreased in women and the estimated glomerular filtration rate (eGFR) loss was slower than in men. However, the percentage of rapid progressors was similar in both sexes. The best multivariate model predicting rapid progression in men (area under curve (AUC) = 0.92) and women differed. Albuminuria and fractional excretion of phosphate (FEphosphate) were part of the men multivariable model, but not of women. The AUC for the prediction of rapid progression by albuminuria was higher in men than in women, and the albuminuria cut-off points also differed. In women, there was a higher percentage of rapid progressors who had baseline physiological albuminuria.
CONCLUSIONS: Female DKD differs from male DKD: albuminuria was milder and better responsive to therapy, the loss of eGFR was slower and the predictors of rapid progression differed from men: albuminuria was a better predictor in men than in women. Lifestyle factors may contribute to the differences.

Entities:  

Keywords:  albuminuria; diabetic kidney disease; diabetic nephropathy; gender; glomerular filtration rate; mortality; outcomes

Year:  2020        PMID: 32466507     DOI: 10.3390/jcm9061611

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  5 in total

1.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia (Engl Ed)       Date:  2022 Jan-Feb

2.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia       Date:  2021-11-17       Impact factor: 2.033

3.  RICORS2040: the need for collaborative research in chronic kidney disease.

Authors:  Alberto Ortiz
Journal:  Clin Kidney J       Date:  2021-09-23

4.  The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients.

Authors:  Adriana Sierra; Sol Otero; Eva Rodríguez; Anna Faura; María Vera; Marta Riera; Vanesa Palau; Xavier Durán; Anna Costa-Garrido; Laia Sans; Eva Márquez; Vladimir Poposki; Josep Franch-Nadal; Xavier Mundet; Anna Oliveras; Marta Crespo; Julio Pascual; Clara Barrios
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

5.  The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis.

Authors:  María Marques; Paula López-Sánchez; Fernando Tornero; Pedro Gargantilla; Alba Maroto; Alberto Ortiz; José Portolés
Journal:  Clin Kidney J       Date:  2022-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.